Advisory: Alert from Equity-Insider.com was published in error and has been withdrawn
16/12/2025 17:43
An alert on cancer drug developers was inadvertently filed off a commentary by Equity-Insider.com and tagged to Immunome IMNM.O, Prelude Therapeutics PRLD.O, Context Therapeutics CNTX.O, Relay Therapeutics RLAY.O and Oncolytics ONCY.O. The alert has been withdrawn and there will be no substitute. STORY_NUMBER: nTUA1LWBBS STORY_DATE: 16/12/2025 STORY_TIME: 05:18:00 PM GMT ((bangalore.newsroom@thomsonreuters.com))
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202